We are happy to announce our next webinar with the topic “Accelerating oncology drug discovery with label-free imaging” on July 7th and 8th.

In this webinar, Dr. Emma Gibbin, Communications Specialist at Nanolive will discuss the advantages of using label-free live cell imaging in the drug discovery process and show how Nanolive’s automated live cell imaging solution the CX-A, can be used to:

observe unique drug-induced phenotypes that fluorescence microscopy cannot capture
record dynamic cellular responses to drug perturbations
automate in vitro screening studies.

Dr. Gibbin will present novel results from two experimental screens designed to test the phenotypic and morphological responses of pre-adipocyte and cancer cells to 8 inhibitors or modulators of kinase activity.

You can watch the registered webinar on-demand here: Download.

Discover our Immuno-Oncology application page and study our Application Note and other materials!

Immuno-Oncology Application Page

Read our latest news

Newsletter November 2024: Techniques for high-content live cell imaging

Nov 19, 2024 | News

Welcome to the November edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore applications of AI-based cellular analysis for label-free live cell...

Newsletter October 2024: Investigative toxicology without labels

Oct 17, 2024 | News

Welcome to the October edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...

September 2024: High-content imaging for kidney disease research

Sep 17, 2024 | News

Welcome to the September edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of cellular analysis for label-free live cell...

More news